Epidermal Growth Factor Receptor mutations
Epidermal Growth Factor Receptor (EGFR) mutations in non-small cell lung cancer (KPKBSK) especially adenocarcinoma have played an important role in the last 10 years as a therapeutic target. The advanced-stage…